Ifinatamab deruxtecan, a B7-H3-directed antibody–drug conjugate, in patients with advanced solid tumours (IDeate-PanTumor01): dose-escalation results from a phase 1/2 trial
用户uavrgk6RFqwQ
13天前
41
10
已完结
1. 系统已在2026-06-02 16:27:29对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1016/S1470-2045(25)00733-8
文献链接: https://linkinghub.elsevier.com/retrieve/pii/S1470204525007338
其他信息:
出版社: Elsevier BV
作者: Melissa L Johnson; Manish R Patel; Gerald S Falchook; Takafumi Koyama; Martin Gutierrez; Mark M Awad; Sarina A Piha-Paul; Claire F Friedman; Taroh Satoh; Naoko Okamoto; Jasmeet Singh; Naoto Yoshizuka; Hillarie Plessner Windish; Meng Qian; Brittany P Tran; Toshihiko Doi
